Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
1991-4-11
|
| pubmed:abstractText |
Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. Uptake of I-123 labeled HMFG1 is reported in a patient with an orbital metastasis from a primary ovarian adenocarcinoma. Radioimmunoscintigraphy may have a role to play in imaging metastatic orbital neoplasms.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0363-9762
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
15
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
825-7
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:2292158-Adenocarcinoma,
pubmed-meshheading:2292158-Aged,
pubmed-meshheading:2292158-Antibodies, Monoclonal,
pubmed-meshheading:2292158-Female,
pubmed-meshheading:2292158-Humans,
pubmed-meshheading:2292158-Iodine Radioisotopes,
pubmed-meshheading:2292158-Orbital Neoplasms,
pubmed-meshheading:2292158-Ovarian Neoplasms
|
| pubmed:year |
1990
|
| pubmed:articleTitle |
Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma.
|
| pubmed:affiliation |
Department of Nuclear Medicine, St. Bartholomew's Hospital, London, United Kingdom.
|
| pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|